These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25691745)

  • 1. Rectifying RNA splicing errors in hereditary neurodegenerative disease.
    Swanson MS
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2637-8. PubMed ID: 25691745
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
    Yoshida M; Kataoka N; Miyauchi K; Ohe K; Iida K; Yoshida S; Nojima T; Okuno Y; Onogi H; Usui T; Takeuchi A; Hosoya T; Suzuki T; Hagiwara M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2764-9. PubMed ID: 25675486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia.
    Hervé M; Ibrahim EC
    Neurobiol Dis; 2017 Jul; 103():113-122. PubMed ID: 28404519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
    Anderson SL; Qiu J; Rubin BY
    Biochem Biophys Res Commun; 2003 Oct; 310(2):627-33. PubMed ID: 14521957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
    Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
    Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia.
    Anderson SL; Qiu J; Rubin BY
    Biochem Biophys Res Commun; 2003 Jun; 306(1):303-9. PubMed ID: 12788105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
    Liu B; Anderson SL; Qiu J; Rubin BY
    FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceutical-mediated restoration of wild-type levels of IKBKAP-encoded IKAP protein in familial dysautonomia-derived cells.
    Anderson SL; Liu B; Qiu J; Sturm AJ; Schwartz JA; Peters AJ; Sullivan KA; Rubin BY
    Mol Nutr Food Res; 2012 Apr; 56(4):570-9. PubMed ID: 22495984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the
    Ohe K; Yoshida M; Nakano-Kobayashi A; Hosokawa M; Sako Y; Sakuma M; Okuno Y; Usui T; Ninomiya K; Nojima T; Kataoka N; Hagiwara M
    RNA; 2017 Sep; 23(9):1393-1403. PubMed ID: 28592461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.
    Hims MM; Ibrahim EC; Leyne M; Mull J; Liu L; Lazaro C; Shetty RS; Gill S; Gusella JF; Reed R; Slaugenhaupt SA
    J Mol Med (Berl); 2007 Feb; 85(2):149-61. PubMed ID: 17206408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
    Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
    Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.
    Bochner R; Ziv Y; Zeevi D; Donyo M; Abraham L; Ashery-Padan R; Ast G
    Hum Mol Genet; 2013 Jul; 22(14):2785-94. PubMed ID: 23515154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells.
    Keren H; Donyo M; Zeevi D; Maayan C; Pupko T; Ast G
    PLoS One; 2010 Dec; 5(12):e15884. PubMed ID: 21209961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the therapeutic efficacy of tocotrienols in neurodegenerative familial dysautonomia patients be measured clinically?
    Rubin BY; Anderson SL; Kapás L
    Antioxid Redox Signal; 2008 Apr; 10(4):837-41. PubMed ID: 18177231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of aberrant splicing in human RNA diseases by chemical compounds.
    Kataoka N
    Hum Genet; 2017 Sep; 136(9):1237-1245. PubMed ID: 28364159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial dysautonomia (Riley-Day syndrome): when baroreceptor feedback fails.
    Norcliffe-Kaufmann L; Kaufmann H
    Auton Neurosci; 2012 Dec; 172(1-2):26-30. PubMed ID: 23178195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia.
    Ibrahim EC; Hims MM; Shomron N; Burge CB; Slaugenhaupt SA; Reed R
    Hum Mutat; 2007 Jan; 28(1):41-53. PubMed ID: 16964593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new function for the Elongator complex: polarization of Rab activity?
    Brennwald P
    Dev Cell; 2005 Apr; 8(4):454-6. PubMed ID: 15809026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of
    Ueki Y; Ramirez G; Salcedo E; Stabio ME; Lefcort F
    eNeuro; 2016; 3(5):. PubMed ID: 27699209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasia in familial dysautonomia: a 20-year review in a young patient population.
    Gold-von Simson G; Romanos-Sirakis E; Maayan C; Axelrod FB
    J Pediatr; 2009 Dec; 155(6):934-6. PubMed ID: 19914433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.